Daily non-political popular news in brief.

The quest for an effective HIV vaccine presents new possibilities, challenges

A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at NIAID. Rather, the first successful preventive HIV vaccines, if administered prior to HIV infection, may reduce HIV levels in the body, thereby delaying the progression to AIDS and the need to start antiretroviral drugs.

Read more »

Keywords: quest, effective, hiv, vaccine, presents, possibilities, challenges, present, possibility, challenge

« Previous | Next »

Similar news on "The quest for an effective HIV vaccine presents new possibilities, challenges":

1. Vaccine hope for malaria
   05-23-2007 · EurekAlert!
   One person dies of it every 30 seconds, it rivals HIV and tuberculosis as the world's most deadly infection and the vast majority of its victims are under five years old. Now, just over 100 years since Britain’s Sir Ronald Ross was awarded the Nobel Prize for finally proving that malaria is transmitted by mosquitoes, researchers at The University of Nottingham believe they have made a significant breakthrough in the search for an effective vaccine.
   Similar news · Read more »
   
2. New HIV vaccine target could solve mutation problem
   11-08-2007 · EurekAlert!
   While HERV are present in every cell, HIV may disrupt the normal constraints on HERV activity as it alters the cell to produce more HIV. A vaccine could be created containing HERV antigens that would stimulate T-cells targeting cells expressing HERV. Although the vaccine would not produce T-cells capable of recognizing HIV itself, it would evoke immune responses that could still protect people from becoming infected or limit the extent of damage caused by HIV.
   Similar news · Read more »
   
3. New publication presents latest in HIV/TB treatment, research
   07-16-2007 · EurekAlert!
   With HIV infection driving a deadly resurgence of tuberculosis, a new publication provides up-to-date recommendations for clinicians facing the many challenges of treating patients with both of these two complex diseases. The publication, a supplement to the Aug. 15 issue of the Journal of Infectious Diseases, is now available online.
   Similar news · Read more »
   
4. Chronic HIV-1 infection frequently fails to protect against superinfection
   11-15-2007 · EurekAlert!
   Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published Nov. 16 in PLoS Pathogens. The team of researchers show how HIV-1 vaccines may not be as reliable against superinfection as once thought. This study suggests that immune responses found in natural HIV-1 infection may not be the best path to an effective HIV-1 vaccine.
   Similar news · Read more »
   
5. Vaccine to cope with viral diversity in HIV
   04-26-2007 · EurekAlert!
   The ability of HIV-1 to develop high levels of genetic diversity and acquire mutations to escape immune pressures contributes to our difficulties in producing a vaccine. David Nickle et al present here an efficient algorithm to develop vaccines that cope with the diversity of HIV or other variable pathogens.
   Similar news · Read more »
   
6. Novel genetics research advances possibility of HIV vaccine
   07-05-2007 · EurekAlert!
   A pioneering collaborative study has discovered how the HIV virus evades the human body's immune system. The research collaborative -- involving scientists from the British Columbia Centre for Excellence in HIV/AIDS, Massachusetts General Hospital, Microsoft Research and Los Alamos National Laboratory -- used highly computer-intensive, cutting-edge statistical research methods to investigate how the HIV virus mutates to escape the body's immune system.
   Similar news · Read more »
   
7. New study suggests potential for a broadly-protective HIV vaccine
   05-29-2007 · EurekAlert!
   New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus. HIV is extremely variable, so an effective vaccine may need to stimulate the body to produce cross-reactive antibodies that will neutralize multiple viral strains. These results demonstrate that induction of truly broad-spectrum neutralizing antibodies may be an achievable goal.
   Similar news · Read more »
   
8. Uncovering the Achilles' heel of the HIV-1 envelope
   01-11-2008 · EurekAlert!
   New structural details illustrate how a promising class of antibodies may block human immunodeficiency virus (HIV)-1 infection and reveal valuable clues for design of an effective HIV-1 vaccine.
   Similar news · Read more »
   
9. A model for tackling the energy challenge
   12-20-2006 · Massachusetts Institute of Technology (MIT)
   In this opinion piece, President Susan Hockfield argues that the commitment of universities and their students offers a compelling model for an effective national response to the science, technology, and policy challenges posed by our energy needs.
   Similar news · Read more »
   
10. Jefferson scientists find rabies-based vaccine could be effective against HIV
    04-03-2007 · EurekAlert!
    Rabies, a relentless, ancient scourge, may hold a key to defeating another implacable foe: HIV. Scientists have used a drastically weakened rabies virus to ferry HIV-related proteins into animals, in essence, vaccinating them against an AIDS-like disease. Early evidence indicates that the vaccine -- which doesn’t protect against infection -- prevents development of disease. Two years after the initial vaccination, four non-human primates were protected from disease, even after being "challenged" with a dangerous animal-human virus.
    Similar news · Read more »